Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 7 | BMC Medicine

Fig. 7

From: Helicobacter pylori SlyD stabilizes TPT1 via hnRNPK and enhances OCT1-mediated CDX2 transcriptional activation to drive gastric intestinal metaplasia

Fig. 7

H. pylori SlyD is related to the expression of hnRNPK, TPT1, OCT1, and CDX2 in the IM of human gastric mucosa. A Representative images of hnRNPK/TPT1/OCT1/CDX2 IHC staining in GS and GIM, respectively (Magnification: ×100). B Comparison of semiquantitative scores of hnRNPK/TPT1/OCT1/CDX2 protein expression in GS (n=18) and GIM (n=52). C Comparison of semiquantitative scores of hnRNPK/TPT1/OCT1/CDX2 protein expression in H. pylori-negative (n=22) or H. pylori-positive (n=48) cases. D Comparison of semiquantitative scores of hnRNPK/TPT1/OCT1/CDX2 protein expression in HpslyD-negative (n=19) or HpslyD-positive (n=29) cases. E The scatter plots of hnRNPK and TPT1 expressions, OCT1 and TPT1 expressions, and OCT1 and CDX2 expressions, respectively in H. pylori-negative (n=14) or H. pylori-positive (n=38), and HpslyD-negative (n=13) or HpslyD-positive (n=25) cases. Significance Levels: *P< .05, **P< .01, ***P < .001, ns: non-significant

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us